ElevateBio raises $150 million to launch cell and gene therapy incubator

ElevateBio has closed a $150 million series A financing round and launched a full-spectrum cell and gene therapy incubator called ElevateBio BaseCamp, in Cambridge, USA.

Describing itself as a “biotechnology holding company,” ElevateBio is seeking to form partnerships to create and build a portfolio of cell and gene therapy firms.

The company is offering centralized “bench-to-bedside” capabilities including scientific expertise, manufacturing facilities, drug development and commercialization expertise, through its hub for R&D, process development and cGMP manufacturing.